TAB HAGLITE SR 500MG

Haglite SR 500 Tablets contain Tranexamic Acid 500 mg in a sustained-release formulation that helps provide prolonged therapeutic action. Tranexamic Acid is an antifibrinolytic agent that works by helping stabilize blood clots and reducing excessive bleeding. The sustained-release technology allows for gradual release of the active ingredient, supporting effective management of bleeding-related conditions as prescribed by a healthcare professional.

Key Benefits

• Sustained-release formulation for prolonged action
• Helps reduce excessive bleeding episodes
• Supports blood clot stabilization
• Convenient tablet dosage form
• Designed for consistent therapeutic effect
• Suitable for use under medical supervision

How to Use

1. Take the tablet exactly as prescribed by your healthcare professional.
2. Swallow the tablet whole with water.
3. Do not crush, chew, or break the sustained-release tablet.
4. Follow the prescribed dosage schedule carefully.

Recommended Use: Use only under the guidance of a qualified healthcare professional.

Safety Information

• Prescription medication; use only as directed by a physician
• Do not exceed the recommended dosage
• Inform your doctor about any existing medical conditions or medications
• Seek immediate medical attention if unusual side effects occur
• Store in a cool, dry place away from direct sunlight
• Keep out of reach of children

Ideal For

• Individuals requiring management of excessive bleeding conditions
• Patients prescribed Tranexamic Acid therapy
• Conditions requiring antifibrinolytic treatment under medical supervision

Additional Information

• Active Ingredient: Tranexamic Acid 500 mg
• Sustained Release (SR) Tablet Formulation
• Antifibrinolytic Medication
• Prescription Product (Rx)
• Pack Size: 10 x 10 Tablets
• Designed for Controlled Drug Release
• To be used under healthcare professional supervision only